CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)
The CBER is the center in the FDA responsible for the following:
Acceptance and review of an investigational new drug application (INDA) prior to initiating a clinical trial;
Review and issuance of a biologics license;
Post-marketing surveillance of approved biologics.